Pentixapharm Ag
Clinical trials sponsored by Pentixapharm Ag, explained in plain language.
-
New brain scan tested to predict lymphoma treatment success
Diagnosis TerminatedThis study aimed to see if a special PET scan could predict how well brain lymphoma patients respond to chemotherapy. Only one person took part before the study was stopped early. The scan looks for a protein called CXCR4 on cancer cells to help guide treatment decisions.
Phase: PHASE2 • Sponsor: Pentixapharm AG • Aim: Diagnosis
Last updated May 26, 2026 10:11 UTC
-
New imaging agent put to the test in lymphoma staging trial – but study ends early
Diagnosis TerminatedThis study tested a new imaging agent called [68Ga]Ga-PentixaFor to see if it could better detect tumors in people with marginal zone lymphoma compared to the standard FDG PET scan. The trial planned to enroll many participants but was stopped early after only 8 people joined. Th…
Phase: PHASE3 • Sponsor: Pentixapharm AG • Aim: Diagnosis
Last updated May 22, 2026 14:05 UTC